Back to Sectors

GPAT

GP-Act III Acquisition Corp.
5 filings tracked
financialsasset managementSMALL ($300M-2B)

Signal Magnitude Chart

NEUTRAL | 40% | 3/26/2026 | capital raiseBULLISH | 70% | 3/26/2026 | margin expansionBEARISH | 80% | 3/26/2026 | dilution riskBULLISH | 60% | 5/13/2026 | capital raiseBEARISH | 40% | 5/13/2026 | dilution riskNEUTRAL | 20% | 5/13/2026 | management changeBULLISH | 60% | 5/13/2026 | capital raiseBEARISH | 40% | 5/13/2026 | dilution riskNEUTRAL | 20% | 5/13/2026 | management changeNEUTRAL | 60% | 5/14/2026 | capital raiseBEARISH | 70% | 5/14/2026 | margin compressionBEARISH | 80% | 5/14/2026 | dilution riskNEUTRAL | 60% | 5/14/2026 | capital raiseBEARISH | 70% | 5/14/2026 | margin compressionBEARISH | 80% | 5/14/2026 | dilution riskMar 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

neutralMay 14

Sponsor provided funding via promissory notes to cover operating deficits.

capital raise
60%
bearishMay 14

G&A expenses increased 180% YoY while interest income declined.

margin compression
70%
bearishMay 14

Massive redemptions of $215M reduced the trust's ability to fund a large acquisition.

dilution risk
80%
neutralMay 14

Sponsor provided funding via promissory notes to cover operating deficits.

capital raise
60%
bearishMay 14

G&A expenses increased 180% YoY while interest income declined.

margin compression
70%
bearishMay 14

Massive redemptions of $215M reduced the trust's ability to fund a large acquisition.

dilution risk
80%
bullishMay 13

Secured non-redemption agreements to preserve trust account capital.

capital raise
60%
bearishMay 13

Sponsor transferring founder shares to investors to secure votes.

dilution risk
40%
neutralMay 13

Strategic shift in shareholder alignment to extend corporate life.

management change
20%
bullishMay 13

Secured non-redemption agreements to preserve trust account capital.

capital raise
60%
bearishMay 13

Sponsor transferring founder shares to investors to secure votes.

dilution risk
40%
neutralMay 13

Strategic shift in shareholder alignment to extend corporate life.

management change
20%
neutralMar 26

Trust account grew to $309.2M through IPO proceeds and interest income.

capital raise
40%
bullishMar 26

Maintained extremely low G&A expenses relative to trust interest income.

margin expansion
70%
bearishMar 26

Sponsor founder shares and deferred underwriting fees create significant potential dilution.

dilution risk
80%

Filing History

10-QMay 14, 2026

The 10-Q filing for GP-Act III Acquisition Corp. presents a classic SPAC tension between a well-funded trust and a deteriorating operational runway. While the company has successfully bought more time and aligned its sponsors, the sheer volume of redemptions has fundamentally altered the risk-reward profile. The company is now operating with a significantly smaller war chest, making the quality of the eventual target business paramount to the success of the venture. Investors are left to weigh the significance of the Sponsor's share transfers and conversions against the reality of a million-dollar working capital deficit. The upcoming months will be critical as the company attempts to leverage its remaining $97.75 million to secure a merger before the November 13, 2026, deadline. The outcome hinges on whether the increased spending on due diligence translates into a viable acquisition or simply accelerates the burn toward liquidation.

8-KMay 13, 2026

GP-Act III Acquisition Corp. is fighting for its survival by trading equity for time. The company has successfully negotiated a path to extend its life until November 13, 2026, by offering founder shares to investors who agree not to redeem their holdings. While this preserves the trust account in the short term, the long-term success of the vehicle now hinges entirely on the management's ability to identify and close a target within the new timeframe. Investors are left weighing the sponsor's conviction against the apparent desperation of the equity giveaway.

10-KMar 26, 2026

The 10-K filing reveals a high-stakes tug-of-war between institutional capability and structural fragility. While the trust is well-funded and the management team is elite, the operational cash void is a critical vulnerability. The company is essentially a well-funded shell with no independent means of survival beyond its trust, making the search for a target a race against time. Ultimately, the investment thesis hinges on the management's ability to leverage their network to secure a high-quality merger before the May 13, 2026, deadline. If they execute, the institutional backing provides a strong floor; if they fail, the structural safeguards for public shareholders are limited, and the sponsor's asymmetric upside remains the only guaranteed win.